Cargando…
Case Report: One-Year Delay in the Effect of Conversion Surgery Therapy for Advanced Hepatocellular Carcinoma After Systemic Therapy
Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed malignancy and the third leading cause of cancer-related deaths worldwide. A 58-year-old man visited his local hospital due to abdominal discomfort and was diagnosed with lung metastasis. After admission to our hospital in April 202...
Autores principales: | Xie, Qing-Yu, Liu, Hai-Yan, Guo, Ze-Yi, Wu, Yan-Ping, He, Guo-Lin, Cai, Lei, Pan, Ming-Xin, Fu, Shun-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855209/ https://www.ncbi.nlm.nih.gov/pubmed/35187075 http://dx.doi.org/10.3389/fmolb.2021.810251 |
Ejemplares similares
-
Macrophage Plasticity and Atherosclerosis Therapy
por: Lin, Ping, et al.
Publicado: (2021) -
Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
por: Li, Xin, et al.
Publicado: (2021) -
Editorial: Interventional therapy of hepatocellular carcinoma
por: Ji, Jiansong, et al.
Publicado: (2022) -
Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis
por: You, Yang, et al.
Publicado: (2021) -
Autoimmune Pemphigus: Latest Advances and Emerging Therapies
por: Lim, Yen Loo, et al.
Publicado: (2022)